Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Elderly-onset gout: a review.

Francesco De Leonardis1, Marcello Govoni, Matteo Colina

  • 1Section of Rheumatology, Department of Clinical and Experimental Medicine, University of Ferrara, Corso della Giovecca, 203, 44100 Ferrara, Italy. dlnfnc@unife.it

Rheumatology International
|July 27, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Hybrid Nanoporous Gold-Cyclodextrin Nanosponge Platforms for Enhanced Model Contaminant Detection.

ACS applied polymer materials·2026
Same author

Cefiderocol in Children with Hematologic Malignancies-The Multicenter Retrospective Experience of the Infection Working Group of the Italian Pediatric Hematology and Oncology Association (AIEOP).

Journal of clinical medicine·2026
Same author

Single-cell template strand sequencing reveals culture-induced chromosomal instability in a gibbon cell line.

Genome research·2026
Same author

Characteristics and Outcome of Patients With Refractory Orbital Rhabdomyosarcoma.

Head & neck·2026
Same author

Deucravacitinib, an oral, selective, allosteric tyrosine kinase 2 inhibitor, in patients with alopecia areata: efficacy and safety results of a phase II, multicenter, randomized, double-blinded, placebo-controlled trial.

The British journal of dermatology·2026
Same author

Correction: Tonon et al. 5-Azacytidine Downregulates the Proliferation and Migration of Hepatocellular Carcinoma Cells In Vitro and In Vivo by Targeting miR-139-5p/ROCK2 Pathway. <i>Cancers</i> 2022, <i>14</i>, 1630.

Cancers·2026
Same journal

Myocarditis as the first sign of SLE: a case report and review of the literature.

Rheumatology international·2026
Same journal

Infrared thermography of the tongue in systemic lupus erythematosus: a pilot study of thermal response to cold stimulation.

Rheumatology international·2026
Same journal

Pre-referral laboratory completeness and diagnostic yield in an early arthritis clinic: a retrospective single-centre analysis.

Rheumatology international·2026
Same journal

Computational intelligence using nailfold videocapillaroscopy for the prediction of carotid intima-media thickness in rheumatoid arthritis: a cohort-based study.

Rheumatology international·2026
Same journal

Frequency and clinical characteristics of hydroxychloroquine-induced pigmentation in Japanese paediatric patients: a retrospective cohort study.

Rheumatology international·2026
Same journal

Predominant HLA class I associations with lupus nephritis susceptibility, histology class and reduced renal function in patients with systemic lupus erythematosus: a retrospective case-control study.

Rheumatology international·2026
See all related articles

Elderly-onset gout (EOG) presents unique challenges in older adults, differing from middle-age gout. Early diagnosis and tailored treatment are crucial for managing this common inflammatory arthropathy in the elderly.

Area of Science:

  • Rheumatology
  • Geriatrics
  • Epidemiology

Background:

  • Elderly-onset gout (EOG), defined as gout starting at age 65+, exhibits distinct characteristics compared to middle-age onset.
  • EOG is the most prevalent inflammatory arthropathy in older populations, significantly impacting clinical practice.

Purpose of the Study:

  • To highlight the epidemiological, clinical, and therapeutic distinctions of EOG.
  • To underscore the challenges in diagnosing and treating gout in the elderly population.

Main Methods:

  • Comparative analysis of EOG versus typical gout presentations.
  • Review of clinical features, associations, and treatment outcomes specific to EOG.

Main Results:

  • EOG often presents with polyarticular involvement, hand/osteoarthritis node tophi, and a higher female-to-male ratio.

Related Experiment Videos

  • Frequent associations include medications affecting renal urate excretion and pre-existing renal impairment.
  • EOG is frequently misdiagnosed or diagnosed late, leading to difficult or unsatisfactory treatment outcomes.

    • Conclusions:

    • EOG represents a significant clinical challenge due to its unique presentation and diagnostic/therapeutic complexities in older adults.
    • Increased awareness and specific management strategies are needed for effective EOG care.